Found: 1
Select item for more details and to access through your institution.
Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome.
- Published in:
- Acta Neuropathologica, 2022, v. 143, n. 5, p. 601, doi. 10.1007/s00401-022-02418-3
- By:
- Publication type:
- Article